NYSE · TFX

Teleflex Incorporated

$132.10 +$0.94 (+0.72%) 1D After hours
Charting by TradingView

Key Metrics

$5.85B
Market cap
—
P/E · TTM
$1.84B
Revenue · TTM
−$1.01B
Net income
EPS · TTM $-21.97
Dividend yield 1.0%
Free cash flow −$14.01M
Beta · 1Y 0.82
EBITDA · TTM −$31.69M
Gross margin 56.4%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 22
    The stock moved +11.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 22

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$5.85B
Enterprise value$8.16B
Shares outstanding44.3M
52-wk range$100.18 – $139.67
Avg volume · 20D451.4K
Net cash −$2.31B
Book value / share$67.16
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNYSE
About Teleflex Incorporated
IPO dateJun 1, 1972
Employees15500

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S3.18
P/FCF—
EV/EBITDA—
EV/Sales4.43
Graham №—

Profitability

Gross 56.4%
Operating -4.8%
Net -54.8%
FCF -0.8%
ROE / ROIC -27.4% · -0.8%

Financial Health

Current ratio2.55
Quick ratio2.03
Debt / equity0.85
Debt / EBITDA -82.59
Net cash −$2.31B
Working capital$1.13B

Cash Flow · TTM

Operating CF $70.00M
Capex −$84.02M
Free cash flow −$14.01M
Buybacks $0
Dividends paid $60.13M
Shareholder yield 1.0%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

1.4
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings